| __timestamp | Amphastar Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 9216000000 |
| Thursday, January 1, 2015 | 174172000 | 8296000000 |
| Friday, January 1, 2016 | 150976000 | 10044000000 |
| Sunday, January 1, 2017 | 149380000 | 11560000000 |
| Monday, January 1, 2018 | 187681000 | 10558000000 |
| Tuesday, January 1, 2019 | 190434000 | 9351000000 |
| Wednesday, January 1, 2020 | 206506000 | 8933000000 |
| Friday, January 1, 2021 | 238029000 | 8284000000 |
| Saturday, January 1, 2022 | 250127000 | 7952000000 |
| Sunday, January 1, 2023 | 293274000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. This analysis delves into the cost of revenue trends for Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Teva's cost of revenue has seen a notable decline of approximately 14%, from $9.2 billion to $8.2 billion. This trend reflects Teva's strategic efforts to optimize its operations amidst global challenges.
Conversely, Amphastar Pharmaceuticals has experienced a significant increase in its cost of revenue, rising by about 84% from $159 million in 2014 to $293 million in 2023. This growth underscores Amphastar's expanding market presence and investment in production capabilities. As these companies navigate the complexities of the pharmaceutical landscape, their cost management strategies will be pivotal in shaping their competitive edge.
Cost Insights: Breaking Down Eli Lilly and Company and Amphastar Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: AstraZeneca PLC vs Amphastar Pharmaceuticals, Inc.
Cost of Revenue Trends: Zoetis Inc. vs Teva Pharmaceutical Industries Limited
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Cytokinetics, Incorporated
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Alkermes plc's Expenses
Cost Insights: Breaking Down Grifols, S.A. and Amphastar Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Supernus Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.